drugset / Trial / NCT00666770

A Polysomnographic Study of Single-Dose Gabapentin in Transient Insomnia Induced by a Sleep Phase Advance

NCT00666770

Phase 3 Completed 309 enrolled Viatris Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to assess the effect of gabapentin as compared to placebo on sleep in subjects with transient insomnia.

Timeline

Start
2004-10
Primary completion
Completion
2004-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule 250 mg Oral
Subject Gabapentin Small molecule 500 mg Oral

Indications